(MENAFNEditorial) iCrowdNewswire - Nov 30, 2017
The rising of the generic string has come with variety of challenges, like significant competition, including approved generics and government-mandated worth cuts. All contribute to decreasing costs and ever decreasing margins. During this era of raised pharmaceutical trade competition, success for drug corporations relies on their ability to manufacture therapeutic-equivalent drug merchandise in a cost-effective and timely manner, whereas conjointly being cognizant of violation and alternative legal and restrictive considerations. Diversification of product portfolios, vertical combination across the producing method, and increasing their geographic presence, particularly into rising markets are a number of the key ways which might be enforced by the generic corporations to beat the present challenges.
The rapid growth of the has come with a number of challenges, such as heavy competition, including from authorized generics and government-mandated price cuts. All contribute to diminishing prices and ever decreasing margins. In this era of increased pharmaceutical industry competition, success for generic medicinecompanies is dependent on their ability to manufacture therapeutic-equivalent medicineproducts in an economical and timely manner, while also being cognizant of patent infringement and other legal and regulatory concerns. Diversification of product portfolios, vertical integration across the manufacturing process, and expanding their geographic presence, especially into emerging markets are some of the key strategies which can be implemented by the generic companies to overcome the existing challenges.
One of the most initial and important step for the development of a prospective generic medicineproduct comprises of product (Active Pharmaceutical Ingredient-API) selection and identification. API is the primary constituent of a pharmaceutical medicineproduct that governs the final cost of the medicineproduct as well as the commercial profit earned by the company. Early access to high-quality active pharmaceutical ingredients (API) that are not infringing patents is critical to success in regulated finished-dose markets as a significant part of generics' profits is made during the early days of their availability.
RequestaSamplecopyofGeneric String MarketReport@
Factors which have to be taken into consideration during the generic product evaluation process include:
- The total geographical and target disease market size.
- Therapeutic areas of the product-whether the medicinein question is approved for a nichecondition or is trying to make a space for itself in the already crowded therapy class.
- Competitor intelligence.
- Current market sales of the innovator product.
- Patent/exclusivity time frame.
- Complexity in the development and time frames.
- Availability of API, equipment and expertise.
- Budget required and return on investment.
Keeping in mind the above mentioned elements we have scrutinized and selected 10 medicinemolecules. This information in the report can aid a prospective generic developer to review and evaluate products which can be incorporated in the company's developmental pipeline.
The therapy classes covered in this report are:
- Oncology
- Cardiovascular
- Respiratory
- Gastroenterology
- Psychiatry
- Infectious disease
The following points were considered while selecting the products:
- Blockbuster medicines with a likelihood of lucrative future sales.
- medicines with novel therapeutic approach for rare disease.
- Specialized products in niche therapeutic markets with no existing competitors.
- Products with robust ongoing clinical trials which will lead to future label expansionsand ultimately act as sales booster.
- First in class medicineproducts with novel targeting mechanism.
TobrowsethefullreportwithTableofContents,clickthelinkbelow:
About Bharat Book Bureau :
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact Information:
Contact us at :
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email:
Website: www.bharatbook.com
Follow us on : Twitter, Facebook, Linkedin, Google Plus
MENAFN3011201700703403ID1096171650
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.